Schedule 13G ownership disclosure
Benitec Biopharma Inc
Security class unavailable · CUSIP: 08205P209
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 264,510
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-002844
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Apr 11, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership